Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/25/2003US6538017 Anticoagulants; cardiovascular disorders; central nervous system disorders
03/25/2003US6538015 Anti-HIV pyrazole derivatives
03/25/2003US6538012 Calcium channel blocker and can be used to treat or prevent angina or hypertension.
03/25/2003US6538011 Composition for the antidandruff treatment of the hair and scalp based on an antidandruff active principle and on a hydroxy acid
03/25/2003US6538010 Compounds may be used to treat a variety of other conditions and disease states and reagents for preventing smoking addiction. The present invention also relates to methods and reagents for treating nicotine addiction.
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6538008 Combination of a selective NMDA NR2B antagonist and an opioid analgesic
03/25/2003US6538007 Hydrates and method of antogonizing glycoprotein IIb/IIIa activity using these compounds is also disclosed. antagonist, inhibitor of blood platelets aggregation and inhibitor of the binding of fibrinogen to blood platelets.
03/25/2003US6538005 As inhibitors of phosphodiesterases; therapy
03/25/2003US6538003 Pyridopyranoazepine derivatives, their preparation and their therapeutic application
03/25/2003US6538001 Crystalline modification of 5-fluoro-1-(tetrahydro-2-furyl) uracil and complex compounds based thereon, producing antineoplastic effect
03/25/2003US6537997 Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
03/25/2003US6537995 Heterocyclic carboxamides
03/25/2003US6537993 Compounds for enhancing chemotherapy
03/25/2003US6537992 Regulation of organic nitrate tolerance
03/25/2003US6537991 A method of treating a peripheral neuropathic pain in a warm-blooded animal requiring such treatment which comprises administering to said animal a therapeutically effective amount of an EP1-type prostaglandin receptor antagonist
03/25/2003US6537990 Combined preparations comprising morpholine anthracyclines and anticancer agent
03/25/2003US6537989 A process for preparing compounds of the formula I as claimed in claim 3, wherein the nucleophilically replaceable group L is halide, C1-C4-alkylsulfonate, C1-C12-alkylphenylsulfonate or mono C1-C4-alkyl sulfate.
03/25/2003US6537988 Synergistic methods and compositions for treating cancer
03/25/2003US6537985 Antibiotic formulation and a method of making this formulation
03/25/2003US6537984 Contacting a targeted solid tumor cell population with a combination of a vinca alkaloid selected from vinblastine, vincristine, vinorelbine, and a triptolide in combination dosage to reduce the targeted tumor cell population
03/25/2003US6537983 Anti-inflammatory androstane derivatives
03/25/2003US6537982 Method of treating prostatic diseases using active vitamin D analogues
03/25/2003US6537980 Vitamin D analogues and their pharmaceutical use
03/25/2003US6537978 Oral administration of effective amounts of forms of hyaluronic acid
03/25/2003US6537977 Anti-inflammatory agent
03/25/2003US6537976 Dialysis solutions containing water soluble vitamins and nutrients
03/25/2003US6537975 Aryl phosphate derivatives of d4T with para-bromo substitution on the aryl group show markedly increased potency as anti-HIV agents without undesirable levels of cytotoxic activity. In particular, these derivatives are potent
03/25/2003US6537974 Method of treating arrhythmias
03/25/2003US6537970 The invention relates to a novel pharmaceutical combination comprising clindamycin and clotrimazole for use for vaginal infections.
03/25/2003US6537969 Nutritional supplement for cerebral metabolic insufficiencies
03/25/2003US6537933 Silk cloths for protecting affected parts
03/25/2003US6537820 Method for producing purified hematinic iron-saccharidic complex and product produced
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537775 Gene involved in cadasil, method of diagnosis and therapeutic application
03/25/2003US6537774 UPS (undecaprenyl diphosphate synthase
03/25/2003US6537593 Plant phenol as new hepatoprotective agents
03/25/2003US6537592 Extracts of kava-kava
03/25/2003US6537586 Apparatus and method for preparing microparticles
03/25/2003US6537585 Methods and compositions for treating solid tumors
03/25/2003US6537582 Anti-inflammatory pharmaceutical formulations
03/25/2003US6537581 Compositions and methods for treating eye discomfort
03/25/2003US6537580 Stable shaped particles of crystalline organic compounds
03/25/2003US6537579 Compositions and methods for administration of pharmacologically active compounds
03/25/2003US6537578 Once-a-day controlled release sulfonylurea formulation
03/25/2003US6537573 Combination dosage form comprising cetirizine and pseudoephedrine
03/25/2003US6537571 Transdermal therapeutic system containing the active substance scopolamine base
03/25/2003US6537569 Radiation cross-linked hydrogels
03/25/2003US6537568 Releasing therapic dosage to tissues
03/25/2003US6537566 Compositions and methods for the non-invasive treatment of uterine fibroid cells
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537546 Process for macromolecularizing phenolic compounds etc. and use thereof
03/25/2003US6537545 Use of corneal hardening agents in enzymeorthokeratology
03/25/2003US6537538 Polystyrene sulfonate inhibits Trichomonas, Gardnerella, and other vaginitis/vaginosis-causing bacteria
03/25/2003US6537524 Inflammatory or obstructive airways disease
03/25/2003US6536450 Fluid heating system for processing semiconductor materials
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2423364A1 Preventives/remedies for emotional disorders
03/25/2003CA2405202A1 Pharmaceutical composition containing two active ingredients for smoking cessation
03/25/2003CA2399569A1 Diagnostic markers and drug targets for treatment of cancer
03/25/2003CA2379005A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/25/2003CA2301599C Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
03/25/2003CA2243657C Compositions for treatment of erectile dysfunction
03/25/2003CA2237221C Protein kinase c inhibitor
03/25/2003CA2234319C Fluoro-substituted adamantane derivatives
03/25/2003CA2232749C Truncated glial cell line-derived neurotrophic factor
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2201723C Colchicine derivatives and the therapeutical use thereof
03/25/2003CA2200480C New use of prostaglandins
03/25/2003CA2149052C Dry mix formulation for bisphosphonic acids
03/25/2003CA2113908C 1-[n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2- nitroethylene derivatives for controlling fleas in domestic animals
03/25/2003CA2107961C Injectable mesna solutions
03/25/2003CA2065496C Treatment of aphthous ulcers and other mucocutaneous disorders
03/25/2003CA2059783C Salts of 2-(2,6-dichloroanilino)-phenylacetic acid, a process for their preparation and their use for pharmaceutical preparations to be applied locally
03/25/2003CA2051239C Prodrugs of phosphonates
03/21/2003WO2002026702A1 Phenoxyphenyl alkane sulfonates
03/21/2003WO2002026230A1 Remedies for inflammatory bowel diseases
03/21/2003WO2002022555A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
03/21/2003CA2423423A1 Medecines of ulcerative colitis
03/21/2003CA2423171A1 Phenoxyphenyl alkane sulfonates
03/20/2003WO2003023066A1 Expression profiling in the intact human heart
03/20/2003WO2003023048A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
03/20/2003WO2003023045A1 Sulfated polysaccharides, process for producing the same and substances having the same as the active ingredient
03/20/2003WO2003023015A2 Method for expression of small antiviral rna molecules within a cell
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022994A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022864A1 17alpha-hydroxy-14beta-steroids with hormonal effect
03/20/2003WO2003022861A1 Process for the preparation of rebeccamycin and analogs thereof
03/20/2003WO2003022860A1 Synthetic heparin pentasaccharides
03/20/2003WO2003022856A1 Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases
03/20/2003WO2003022855A1 Tert-butoxy dihydro artimisinin, its production and pharmaceutical composition
03/20/2003WO2003022853A1 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol
03/20/2003WO2003022852A2 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
03/20/2003WO2003022849A1 Carbazole derivatives and their use as npy5 receptor antagonists
03/20/2003WO2003022846A1 1-glyoxlylamide indolizines for treating cancer
03/20/2003WO2003022845A1 Pyrazolo-pyridines for the treatment of herpes infections
03/20/2003WO2003022844A2 Synthesis of epothilones intermediates thereto and analogues thereof
03/20/2003WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003WO2003022840A1 Pyridine derivatives as raf kinase inhibitors
1 ... 5526 5527 5528 5529 5530 5531 5532 5533 5534 5535 5536 5537 5538 5539 5540 5541 5542 5543 5544 5545 5546 ... 7860